Our acceleration program VITA, born from an initiative of CDP Venture Capital SRG in collaboration with Healthware Group and Accelerace, is supported by a vast network of ecosystem partners
During Sprint 3 of our acceleration program, we organized a "Meet the Investors" session with the support of the our Innovation Partner Zcube-Zambon Research Venture
InGeno is the first platform that, starting with an innovative and patented DNA analysis, allows people to go to the source of the problem by developing genetically-based personalized treatment programs.
The Vita Accelerator is a novel startup acceleration program launched by CDP together with Healthware and Accelerace that aims to support a new generation of digital health startups.